We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Perimeter Solutions
PRM
$5.77B
| $1.4M | ﹤0.01% |
228,086
+46,512
| +26% | +$312K |
|
2102
Coeur Mining
CDE
$17.9B
| $1.4M | ﹤0.01% |
493,192
+47,263
| +11% | +$161K |
|
|
FLNA
2103
Filana Therapeutics
FLNA
$48.1M
| $1.4M | ﹤0.01% |
57,001
+4,448
| +8% | +$107K |
|
|
NVRO
2104
DELISTED
NEVRO CORP.
NVRO
| $1.39M | ﹤0.01% |
54,839
+7,759
| +16% | +$224K |
|
|
BFS
2105
Saul Centers
BFS
$841M
| $1.39M | ﹤0.01% |
37,735
-5,705
| -13% | -$205K |
|
2106
Clean Energy Fuels
CLNE
$347M
| $1.39M | ﹤0.01% |
279,912
-2,249
| -0.8% | -$9.85K |
|
|
HIBB
2107
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.39M | ﹤0.01% |
38,222
-143
| -0.4% | -$6.84K |
|
2108
Ennis
EBF
$564M
| $1.39M | ﹤0.01% |
68,002
+1,304
| +2% | +$26.3K |
|
2109
Enanta Pharmaceuticals
ENTA
$400M
| $1.39M | ﹤0.01% |
64,744
+882
| +1% | +$26K |
|
2110
Live Oak Bancshares
LOB
$1.97B
| $1.39M | ﹤0.01% |
52,661
+5,875
| +13% | +$138K |
|
|
NUVL
2111
DELISTED
Nuvalent
NUVL
| $1.38M | ﹤0.01% |
32,771
+456
| +1% | +$17.2K |
|
|
BRSP
2112
BrightSpire Capital
BRSP
$648M
| $1.38M | ﹤0.01% |
205,142
+39,078
| +24% | +$232K |
|
|
CBAY
2113
DELISTED
Cymabay Therapeutics
CBAY
| $1.38M | ﹤0.01% |
+126,026
| New | +$1.17M |
|
|
LGTY
2114
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $1.38M | ﹤0.01% |
131,301
+371
| +0.3% | +$4.47K |
|
2115
Repay Holdings
RPAY
$327M
| $1.38M | ﹤0.01% |
175,935
+39,839
| +29% | +$268K |
|
2116
Fluence Energy
FLNC
$2.44B
| $1.38M | ﹤0.01% |
51,675
+4,176
| +9% | +$93.4K |
|
2117
KE Holdings
BEKE
$18.8B
| $1.38M | ﹤0.01% |
+92,671
| New | +$1.51M |
|
2118
Immunovant
IMVT
$8.25B
| $1.37M | ﹤0.01% |
72,198
+550
| +0.8% | +$10.3K |
|
|
LBAI
2119
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.37M | ﹤0.01% |
102,001
-23,392
| -19% | -$326K |
|
2120
Sumitomo Mitsui Financial
SMFG
$164B
| $1.37M | ﹤0.01% |
+158,772
| New | +$1.31M |
|
2121
Hayward Holdings
HAYW
$3.36B
| $1.36M | ﹤0.01% |
106,001
+32,551
| +44% | +$376K |
|
|
THR
2122
DELISTED
Thermon Group Holdings
THR
| $1.36M | ﹤0.01% |
51,149
-144
| -0.3% | -$3.34K |
|
2123
AngioDynamics
ANGO
$649M
| $1.36M | ﹤0.01% |
130,288
+3,427
| +3% | +$33K |
|
2124
QuinStreet
QNST
$1.21B
| $1.35M | ﹤0.01% |
153,191
-13,677
| -8% | -$138K |
|
|
ACCD
2125
DELISTED
Accolade Inc
ACCD
| $1.35M | ﹤0.01% |
100,089
-10,046
| -9% | -$130K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.